Cargando…

The Incidence and Severity of COVID-19 in the Liverpool Severe Asthma Population Undergoing Biologic Therapy

Background The coronavirus disease 2019 (COVID-19) infection can have a variable impact on patients. Various host factors have been identified that play a significant role in the risk of COVID-19 infection and its severity. Patients with severe asthma have been clinically vulnerable since the first...

Descripción completa

Detalles Bibliográficos
Autor principal:	Abdullah, Yahya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443068/ https://www.ncbi.nlm.nih.gov/pubmed/36105903 http://dx.doi.org/10.7759/cureus.28790

Ejemplares similares

The Incidence and Severity of COVID-19 Infection Post Vaccination in Saudi Arabia
por: Jamous, Yahya F, et al.
Publicado: (2023)

Measles outbreaks in the UK, is it when and where, rather than if? A database cohort study of childhood population susceptibility in Liverpool, UK
por: Keenan, Alex, et al.
Publicado: (2017)

Predictors of Severity in Covid-19 Patients in Casablanca, Morocco
por: El Aidaoui, Karim, et al.
Publicado: (2020)

IL-6 and other biomarkers as predictors of severity in COVID-19
por: Broman, N., et al.
Publicado: (2021)

Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial
por: Lovre, Dragana, et al.
Publicado: (2021)

Prehospital physiological parameters related illness severity scores can accurately discriminate the severe/critical state in adult patients with COVID-19
por: Li, Chen, et al.
Publicado: (2023)

Successful Treatment of Elderly Male With COVID-19 Infection With Severe Acute Respiratory Distress Syndrome Using Multimodal Therapy, Including Immune Modulation Therapy
por: Jitsuiki, Kei, et al.
Publicado: (2020)

Sequential Shifting in T-helper and T-cytotoxic Subset Cell Population in Mild and Severe COVID-19 Patients Infected With Variant B.1.61
por: Agarwal, Jyotsna, et al.
Publicado: (2023)

Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia
por: Joshi, Deepti, et al.
Publicado: (2021)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia
por: Staiano, Peter P, et al.
Publicado: (2022)

Is There a Gender Difference in Terms of Inflammatory Biomarkers in Patients With Severe Covid-19 Pneumonia?
por: Akkurt, Esma Sevil, et al.
Publicado: (2022)

Examining the Determinants of COVID-19 Severity: A Cohort Study in Morocco of 915 Patients
por: Mahdi, Zaynab, et al.
Publicado: (2022)

Severity Status of COVID-19 and Its Associated Factors at the Nyarugenge Treatment Center in Rwanda
por: Ntambara, James, et al.
Publicado: (2023)

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
por: Pizzamiglio, Chiara, et al.
Publicado: (2022)

Post-COVID Syndrome and Severity of COVID-19: A Cross-Sectional Epidemiological Evaluation From North India
por: Uniyal, Nidhi, et al.
Publicado: (2022)

Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study
por: Hodges, Gethin, et al.
Publicado: (2020)

The Incidence of Respiratory Infections and Risk Factors Among Cancer Patients Undergoing Chemotherapy at a Tertiary Care Hospital in Western Saudi Arabia
por: Alharbi, Abdulaziz F, et al.
Publicado: (2022)

Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
por: Mallick, Taha, et al.
Publicado: (2020)

Prevalence of Hospital-Acquired Pneumonia Among Patients With Severe to Critical COVID-19 Pneumonia Given Tocilizumab
por: Adre, Lorenzo Abednego B, et al.
Publicado: (2023)

Mitigating the Burden of Severe Pediatric Respiratory Viruses in the Post-COVID-19 Era: ChatGPT Insights and Recommendations
por: Alhasan, Khalid, et al.
Publicado: (2023)

Craniofacial Pain Management in Severe COVID-19 Patients During the Pandemic Peak in Kosovo: A Comprehensive Approach
por: Krasniqi, Valon, et al.
Publicado: (2023)

Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities
por: Nouh, Fatimah A, et al.
Publicado: (2022)

The Relationship Between Vitamin D Status and the Clinical Severity of COVID-19 Infection: A Retrospective Single-Center Analysis
por: Zidrou, Christiana, et al.
Publicado: (2022)

A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing
por: Shchetinin, Alexey M, et al.
Publicado: (2021)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea
por: Jung, Younghee, et al.
Publicado: (2021)

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity
por: Virhammar, Johan, et al.
Publicado: (2021)

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study
por: Hoeter, Katharina, et al.
Publicado: (2023)

Nitrofurantoin-associated Acute Pulmonary Toxicity Mimicking Severe Sepsis with Significantly Elevated Procalcitonin
por: Khan, Tahir Muhammad Abdullah, et al.
Publicado: (2019)

Human Leukocyte Antigen (HLA) Class I Susceptible Alleles Against COVID-19 Increase Both Infection and Severity Rate
por: Ishii, Tomoo
Publicado: (2020)

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh
por: Hasan, Md Jahidul, et al.
Publicado: (2022)

Association between cardiometabolic disease and severe COVID-19: a nationwide case–control study of patients requiring invasive mechanical ventilation
por: Svensson, Per, et al.
Publicado: (2021)

Perspectives on COVID-19 Vaccines and Its Hesitancy Among Jordanian Population
por: Abdullah, Mohamad, et al.
Publicado: (2022)

Pneumomediastinum in a patient with severe Covid-19 pneumonia
por: Chang, Chee Yik
Publicado: (2021)

Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors
por: Quilliot, Didier, et al.
Publicado: (2021)

Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data
por: Yokomichi, Hiroshi, et al.
Publicado: (2019)

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
por: Li, Chuan, et al.
Publicado: (2021)

Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
por: Kandi, Venkataramana, et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Aspergillosis Complicated by Severe Coronavirus Disease: Is Detection of Aspergillus in Airway Specimens Before Disease Onset an Indicator of Antifungal Prophylaxis?
por: Kitayama, Takaaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t41h28543oh5u0klfsb5bgvq93